The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Relationship of infusion duration to safety, efficacy, and pharmacodynamics (PD): Second part of a phase I-II study using VSV-IFNβ-NIS (VV1) oncolytic virus in patients with refractory solid tumors.
 
Jaime R. Merchan
Consulting or Advisory Role - Exelixis
Research Funding - Corvus Pharmaceuticals (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Novartis (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Replimune (Inst); Rexahn Pharmaceuticals (Inst); Seattle Genetics/Astellas (Inst); Sillajen (Inst); Tizona Therapeutics, Inc. (Inst); Tizona Therapeutics, Inc. (Inst); Tocagen (Inst); Vyriad (Inst)
 
Manish Patel
Consulting or Advisory Role - Nektar
 
Timothy P. Cripe
No Relationships to Disclose
 
Matthew O. Old
No Relationships to Disclose
 
James Fredric Strauss
Employment - Dialectic Therapeutics
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Bristol-Myers Squibb; Intuitive Surgical; Johnson & Johnson; Merck
Consulting or Advisory Role - Tempus
Other Relationship - Dialectic Therapeutics
 
Amber Thomassen
No Relationships to Disclose
 
Rosa M Diaz
Employment - Vyriad
Travel, Accommodations, Expenses - Vyriad
 
Kah Whye Peng
Employment - Imanis Life Sciences; Vyriad
Leadership - Imanis Life Sciences; Vyriad
Stock and Other Ownership Interests - Imanis Life Sciences; Vyriad
 
Stephen J. Russell
Stock and Other Ownership Interests - Imanis Life Sciences; Vyriad
Patents, Royalties, Other Intellectual Property - As a Mayo Clinic employee I have filed invention disclosures and some of those have been filed as patents. I have assigned my rights in those patents to Mayo Clinic. (Inst)
Travel, Accommodations, Expenses - Vyriad
 
Luke Russell
Employment - Vyriad
Stock and Other Ownership Interests - Vyriad
Patents, Royalties, Other Intellectual Property - Oncolytic Virus expressing PTEN-alpha
 
Monica Reckner
Consulting or Advisory Role - Vyriad
 
Erol Wiegert
Leadership - Mologen
Consulting or Advisory Role - Vyriad
 
Alice Susannah Bexon
Employment - Bexon Clinical Consulting
Leadership - SapVax; Vyriad
Stock and Other Ownership Interests - Sapience Therapeutics; Vyriad
Travel, Accommodations, Expenses - Sapience Therapeutics; Vyriad
 
Steven Francis Powell
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Research Funding - Actuate Therapeutics (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Vyriad (Inst)